All lobbying filings
Moderna, Inc.
Moderna, Inc. filed a Q3 amendment for Moderna, Inc. on March 23, 2026.
Lobbying for Moderna, Inc. · Pharmaceuticals
Filing · LD-2 quarterly report
Q3 amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Mar 23, 2026
Expenses
$100,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Lobbyists on this filing
1
-
SARAH CURTIS New on this filingPreviously held: Chief of Staff, Rep. Manning; Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland
Government bodies contacted
4
Lobbying activity
1
Vaccine Policy